Class information for:
Level 1: DALFAMPRIDINE//FAMPRIDINE//FAMPRIDINE SR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17279 543 31.8 52%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
547 13910 SCORPION TOXINS//SCORPION VENOM//POTASSIUM CHANNEL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DALFAMPRIDINE Author keyword 27 71% 4% 22
2 FAMPRIDINE Author keyword 26 69% 4% 22
3 FAMPRIDINE SR Author keyword 17 100% 1% 8
4 4 AMINOPYRIDINE Author keyword 15 15% 17% 93
5 AMPYRA Author keyword 3 100% 1% 3
6 3 4 DIAMINOPYRIDINE Author keyword 2 17% 2% 12
7 4 AMINOPYRIDINE DERIVATIVES Author keyword 1 100% 0% 2
8 IMMEDIATE RELEASE FAMPRIDINE Author keyword 1 100% 0% 2
9 PULM SECT 111JW Address 1 50% 0% 2
10 ALBERT SZENT GYORGYI HLTH SCI Address 1 33% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DALFAMPRIDINE 27 71% 4% 22 Search DALFAMPRIDINE Search DALFAMPRIDINE
2 FAMPRIDINE 26 69% 4% 22 Search FAMPRIDINE Search FAMPRIDINE
3 FAMPRIDINE SR 17 100% 1% 8 Search FAMPRIDINE+SR Search FAMPRIDINE+SR
4 4 AMINOPYRIDINE 15 15% 17% 93 Search 4+AMINOPYRIDINE Search 4+AMINOPYRIDINE
5 AMPYRA 3 100% 1% 3 Search AMPYRA Search AMPYRA
6 3 4 DIAMINOPYRIDINE 2 17% 2% 12 Search 3+4+DIAMINOPYRIDINE Search 3+4+DIAMINOPYRIDINE
7 4 AMINOPYRIDINE DERIVATIVES 1 100% 0% 2 Search 4+AMINOPYRIDINE+DERIVATIVES Search 4+AMINOPYRIDINE+DERIVATIVES
8 IMMEDIATE RELEASE FAMPRIDINE 1 100% 0% 2 Search IMMEDIATE+RELEASE+FAMPRIDINE Search IMMEDIATE+RELEASE+FAMPRIDINE
9 WALKING IMPAIRMENT 1 18% 1% 4 Search WALKING+IMPAIRMENT Search WALKING+IMPAIRMENT
10 12 ITEM MULTIPLE SCLEROSIS WALKING SCALE 1 50% 0% 1 Search 12+ITEM+MULTIPLE+SCLEROSIS+WALKING+SCALE Search 12+ITEM+MULTIPLE+SCLEROSIS+WALKING+SCALE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IMPROVES CLINICAL SIGNS 32 63% 6% 32
2 FAMPRIDINE SR 19 74% 3% 14
3 MAMMALIAN NERVE FIBERS 19 51% 5% 26
4 4 AMINOPYRIDINE TOXICITY 17 100% 1% 8
5 SUSTAINED RELEASE 4 AMINOPYRIDINE 13 67% 2% 12
6 4 AMINOPYRIDINE SEIZURES 12 86% 1% 6
7 AXONAL CONDUCTION 10 34% 5% 25
8 4 AMINOPYRIDINE 10 12% 14% 76
9 FAMPRIDINE 10 58% 2% 11
10 4 AMINOPYRIDINE DERIVATIVES 8 100% 1% 5

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy) 2013 8 35 69%
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review 2014 7 56 59%
Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis 2011 23 61 49%
The Use of Aminopyridines in Neurological Disorders 2012 12 71 48%
Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons 2011 9 66 68%
Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis 2013 3 31 61%
The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials 2012 7 61 61%
Clinical overview of the seizure risk of dalfampridine 2012 7 32 53%
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment 2012 4 25 68%
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances 2012 2 17 88%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PULM SECT 111JW 1 50% 0.4% 2
2 ALBERT SZENT GYORGYI HLTH SCI 1 33% 0.4% 2
3 DNEPROPETROVSK STATE MED 1 50% 0.2% 1
4 EMERGENCY MED OFF 1 50% 0.2% 1
5 ESCLEROSI MULTIPLE CATALUNYA CEM CATUNITAT N 1 50% 0.2% 1
6 EXTERNAL PHARMACOL SECT 1 50% 0.2% 1
7 GRP EXPT MAGNET ONANCE 1 50% 0.2% 1
8 INSERMCIT 808 1 50% 0.2% 1
9 MULTIPLE SCLEROSIS CNS DEMYELINATING DIS 1 50% 0.2% 1
10 PROGRAM REHABIL GERIATR CARE 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000182511 NERVE EXCITABILITY//THRESHOLD ELECTROTONUS//AXONAL EXCITABILITY
2 0.0000141551 DENDROTOXINS//DENDROTOXIN//MAMBAS
3 0.0000116426 TOOSENDANIN//PRESYNAPTIC BLOCKER//ICBAS PHARMACOL
4 0.0000103585 GUINEA PIG BLADDER//NK2 TACHYKININ RECEPTOR//ACETYCHOLINE RELEASE
5 0.0000096710 MAIN LYMPHATICS//METHODS OF LECTIN HISTOCHEMISTRY//MICROBIOL CELL MEMBRANE TRANSPORT
6 0.0000086682 EYELID PRESSURE//MULTIEXPONENTIAL FITTING//PROPOFOL EMULSION
7 0.0000079989 NODE OF RANVIER//AXON INITIAL SEGMENT//PARANODE
8 0.0000076617 KINESIOL COMMUNITY HLTH//MULTIPLE SCLEROSIS JOURNAL//TIMED 25 FOOT WALK
9 0.0000074231 PAROXYSMAL DEPOLARIZATION SHIFT//TWO COMPARTMENT NEURON//LOW MAGNESIUM ACSF
10 0.0000070492 PAINFUL TONIC SPASMS//PAROXYSMAL ATTACKS//NEUROL HEADACHE